View by type:
Articles (4214)
Video: How Kenya is prioritising routine immunisation services during the COVID-19 pandemic
The Ministry of Health and UNICEF Kenya, with support from Gavi, are working to ensure that routine health services, such as immunisation, continue during the pandemic. Watch their video to learn more.
5 ways COVID-19 is exacerbating global poverty
COVID-19 has presented many new social and economic challenges, and is exacerbating already existing ones. One such challenge is global poverty. Right now over 700 million people live in extreme poverty worldwide, which is defined as living on…
The Human Cost of COVID-19: Gracia
In this third story in the World Health Organization series exploring the human cost of the COVID-19 pandemic, Gracia, a junior high school student in West Papua, learns life skills for the future.
COVAX Facility governance explained
How will the COVAX Facility ensure equitable access to COVID-19 vaccines is indeed equitable? By Aurélia Nguyen, Managing Director, Office of the COVAX Facility
COVAX Facility convenes first meeting of COVAX AMC engagement group
The COVAX AMC Engagement Group, composed of Gavi COVAX AMC participants, donors, and other stakeholders, forms a key component of Facility governance.
'Back to normal by spring': are we expecting too much from the first COVID-19 vaccines?
Pfizer’s update certainly is fantastic news. A COVID-19 vaccine could well be approved and ready for use in the next few months. But whether that means we can all get back to normal life by early 2021 is less certain.
The Human Cost of COVID-19: Shukria
In this second story in the World Health Organization series exploring the human cost of the COVID-19 pandemic, Shukria, a volunteer, talks about how she helps her community with providing masks and awareness messages about COVID-19.
The European Commission, France, Spain, The Republic of Korea and the Bill & Melinda Gates Foundation pledge US$ 360 million to Gavi’s COVID-19 Vaccines Advance Market Commitment (COVAX AMC)
A smart label on vaccine vials will be vital for safely rolling out future COVID-19 vaccines
Interim results suggesting that Pfizer/BioNTech’s COVID-19 vaccine provides more than a 90% efficacy, offers hope that immunisation can be effective against COVID-19. But the need to store this vaccine at “ultra cold” temperatures could pose…
Until a coronavirus vaccine is ready, pneumonia vaccines may reduce deaths from COVID-19
The yearly influenza season threatens to make the COVID-19 pandemic doubly deadly, but I believe that this isn’t inevitable.
The Human Cost of COVID-19: Nombasa
In the first of a World Health Organization series exploring the human cost of the COVID-19 pandemic, Nombasa, a frontline healthworker, makes an urgent appeal to governments and global health partners.
Six in ten children are immune to the COVID-19 virus despite never being infected by it
Immunity triggered by exposure to the coronaviruses that cause the common cold could protect people, especially children, against the SARS-CoV-2 virus.
